I'm tired of people saying the trials failed.
they didn't, some of you really need to stop being so ignorant.
CHF didn't meet the primary endpoint of re-hospitalisation but it smashed the secondary endpoints at 60% reduced mortality how is that a fail? - I see this either getting approved straight up or approval with another confirmatory study.
COVID ARDS - trial ended at the third analysis because DSMB said "may not reach primary endpoint of 43% reduction in mortality"
firstly, since April, the UK has 10x the amount of COVID cases
and 50% less deaths than it did in April, the standard of care is increasing to the point where it makes it hard to distinguish what is, and isn't working43% was also optimistic, MSCs role in repairing the damage don
by COVID is what the secondary endpoints will be looking at, again not a fail if the trial shoes impressive lung repairAlso, the DSMBs job is to ensure the trial continues its course (this point 43% reduction in mortality) the fact it ended means that in the third analysis it did not reach this number, so it's ending the trial, we may still may see 20-30% reduction in mortality while accelerating recovery (which is what we saw during the pilot study, i.e days of ventilators)
srGVHD - again, not a fail, FDA want a "confirmatory study" before approval, who knows? We might see conditional approval based on the TA meeting
- Forums
- ASX - By Stock
- You wanna play with FIRE?
I'm tired of people saying the trials failed.they didn't, some...
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.10 |
Change
0.000(0.00%) |
Mkt cap ! $1.250B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 731 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.04 | 1750 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1075 | 1.145 |
1 | 8000 | 1.130 |
5 | 3260 | 1.125 |
2 | 36 | 1.120 |
4 | 936 | 1.115 |
Price($) | Vol. | No. |
---|---|---|
1.045 | 888 | 1 |
1.070 | 11438 | 1 |
1.075 | 1423 | 5 |
1.080 | 207 | 1 |
1.095 | 2241 | 2 |
Last trade - 10.04am 10/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online